Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
About
This Notice of Funding Opportunity (NOFO) invites applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this NOFO is focused on advancing emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. To be successful, proposed development plans must have a clear rationale for why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from driving cancer research projects as well as the broader user community throughout the development process must be included. This NOFO invites applications for the enhancement and dissemination of emerging, user-friendly informatics technologies that support a wide range of cancer research, including discovery biology, population studies, as well as clinical and translational research. The emphasis is on uniqueness and potential impact on cancer.
The Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) grant is designed for researchers, software developers, and technology innovators who have created emerging informatics solutions with demonstrated potential to transform cancer research. This National Cancer Institute (NCI) funded opportunity supports organizations that have moved beyond initial prototyping and pilot stages and are ready to enhance, refine, and disseminate user-friendly technologies across the cancer research continuum. Eligible applicants include academic institutions, research organizations, technology companies, and international entities collaborating with U.S. organizations. The grant funds the advanced development of informatics technologies that improve data acquisition, analysis, visualization, and interpretation for cancer biology, treatment, diagnosis, early detection, risk assessment, prevention, and epidemiology. Entrepreneurs and innovators should apply if their technology addresses a genuine need in the cancer research community, has clear potential for significant broader impact, and includes mechanisms for gathering feedback from driving cancer research projects and the wider user community. This is an ideal opportunity for those seeking $50,000 to $600,000 in federal funding to scale emerging technologies that could revolutionize how cancer researchers work with data and drive meaningful advancements in cancer care.
Funding Facts
● Applications openDeadline
October 19, 2026
Award Amount
$50K - $600K
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Grant Amount
$50K - $600K
Deadline
2026-10-19
Grant Type
federal
Application Cycle
Annual (Deadline: October 19, 2026)
Best For
Informatics technology innovators, research institutions, software developers, academic centers, and organizations with emerging cancer research technologies ready for advanced development and broader dissemination
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Frequently Asked Questions
Who is eligible for Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)?
Eligible applicants include domestic and non-domestic (foreign) organizations, as well as non-U.S. components of U.S. organizations. Foreign collaborations and foreign components are permitted. For comprehensive eligibility requirements, including organizational type, institutional capacity, and other specific criteria, refer to Section III. Eligibility Information in the official Notice of Funding Opportunity (NOFO) on the NIH/NCI website.
How much funding does Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) provide?
This grant provides funding between $50,000 and $600,000. The specific amount awarded may depend on project scope, budget justification, and review panel recommendations. Verify current funding ranges with the official NCI NOFO, as amounts may vary by funding cycle.
How do I apply for Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)?
Applications are submitted through the NIH grants portal. Your proposal should clearly articulate the need for your technology, its potential impact on the cancer research field, and your plan for gathering user feedback throughout development. You must demonstrate that your technology has moved beyond initial prototyping and shows compelling reasons for further enhancement. Visit the official NCI ITCR Program website and the NIH NOFO page for detailed application instructions, required forms, and submission deadlines.
What can Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) funding be used for?
Funding supports the advanced development and enhancement of emerging informatics technologies that improve data acquisition, analysis, visualization, and interpretation across the cancer research continuum. This includes technologies for cancer biology, treatment and diagnosis, early cancer detection, risk assessment, prevention, cancer control, and epidemiology. Funding may also support dissemination efforts, user engagement mechanisms, and refinement of user-friendly features to ensure broader adoption in the cancer research community.
Last updated: July 5, 2026